Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17536381 | 0.77 | TRPA1 (0.41) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL11465022 | 0.77 | SLC6A9 (0.45) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL516000 | 0.77 | MAOA (0.46) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL21635608 | 0.76 | MAOA (0.41) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL5958283 | 0.75 | NOS3 (0.42) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL28922378 | 0.75 | TRPA1 (0.48) | POLBTRPA1NOS3NOS1NOS2 | |
| SCHEMBL13563553 | 0.75 | TRPA1 (0.44) | POLBTRPA1NOS3NOS1NOS2 | |
| SCHEMBL2761904 | 0.74 | MAOA (0.39) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL9723028 | 0.73 | TRPA1 (0.38) | POLBTRPA1MAOAMAOBNOS3 | |
| SCHEMBL10925912 | 0.72 | NOS3 (0.41) | POLBTRPA1MAOAMAOBNOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2990114-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | National Institute of Advanced Industrial Science and Technology (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990112-A1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
| EP-2990113-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | Maruzen Petrochemical Co., Ltd. (JP) | 2016-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067695-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CYCS, CA7, CA9 | POLB 793/4885TRPA1 4757/4885MAOA 1138/4885 |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | POLB 793/4885TRPA1 4757/4885MAOA 1138/4885 |
| US-20160108071-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | EPHX2, CA4, CA9 | POLB 1146/4885TRPA1 2950/4885MAOA 1719/4885 |
| US-20160060242-A1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | CA2, PLCB3, PHOSPHO1 | POLB 564/4885TRPA1 2799/4885MAOA 3681/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | POLB 1549/4885TRPA1 2630/4885MAOA 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.